Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.5 - $2.33 $52,638 - $81,764
35,092 New
35,092 $52,000
Q4 2021

Feb 14, 2022

SELL
$1.74 - $2.4 $114,128 - $157,418
-65,591 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$2.08 - $3.6 $131,872 - $228,240
-63,400 Reduced 49.15%
65,591 $142,000
Q2 2021

Aug 16, 2021

BUY
$3.36 - $10.56 $267,771 - $841,568
79,694 Added 161.66%
128,991 $451,000
Q1 2021

May 17, 2021

SELL
$9.26 - $14.36 $806,786 - $1.25 Million
-87,126 Reduced 63.86%
49,297 $486,000
Q4 2020

Feb 16, 2021

SELL
$9.84 - $14.26 $65,928 - $95,542
-6,700 Reduced 4.68%
136,423 $1.48 Million
Q3 2020

Nov 16, 2020

BUY
$10.3 - $21.64 $1.47 Million - $3.1 Million
143,123 New
143,123 $1.47 Million
Q2 2019

Aug 14, 2019

SELL
$5.1 - $11.89 $196,380 - $457,836
-38,506 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$3.03 - $6.02 $1.53 Million - $3.04 Million
-504,387 Reduced 92.91%
38,506 $202,000
Q4 2018

Feb 14, 2019

SELL
$2.87 - $5.92 $57,400 - $118,400
-20,000 Reduced 3.55%
542,893 $1.71 Million
Q3 2018

Nov 14, 2018

SELL
$4.5 - $7.6 $1.5 Million - $2.53 Million
-332,356 Reduced 37.12%
562,893 $3.41 Million
Q2 2018

Aug 14, 2018

SELL
$5.3 - $6.9 $2.18 Million - $2.83 Million
-410,799 Reduced 31.45%
895,249 $4.75 Million
Q1 2018

May 15, 2018

BUY
$3.65 - $7.95 $4.77 Million - $10.4 Million
1,306,048 New
1,306,048 $7.58 Million

Others Institutions Holding ADVM

About Adverum Biotechnologies, Inc.


  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $689M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.